Search alternatives:
largest decrease » larger decrease (Expand Search), marked decrease (Expand Search)
less decrease » we decrease (Expand Search), levels decreased (Expand Search)
teer decrease » greater decrease (Expand Search)
Showing 301 - 320 results of 4,486 for search 'significantly ((((less decrease) OR (largest decrease))) OR (((teer decrease) OR (mean decrease))))', query time: 0.38s Refine Results
  1. 301
    Intervention in the CGA-induced activation of the Nrf2 pathway and its inhibition of NLRP3 inflammasome in HK-2 cells.

    Intervention in the CGA-induced activation of the Nrf2 pathway and its inhibition of NLRP3 inflammasome in HK-2 cells. by Liping Bao (2936715)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 302
    Spatial exploration patterns of tumor bearing mice under different treatment conditions in the Morris Water Maze (MWM).

    Spatial exploration patterns of tumor bearing mice under different treatment conditions in the Morris Water Maze (MWM). by Robert Botelho (20308297)

    Published 2024
    Save to List
    Saved in:
  3. 303
    Spatial exploration patterns of non-tumor bearing mice under different treatment conditions in the Morris Water Maze (MWM).

    Spatial exploration patterns of non-tumor bearing mice under different treatment conditions in the Morris Water Maze (MWM). by Robert Botelho (20308297)

    Published 2024
    Save to List
    Saved in:
  4. 304
    Forest Plot of Multivariate Odds Ratios for Risk Factors Associated with Nerve Injury 90 Days After Total Knee Arthroplasty.

    Forest Plot of Multivariate Odds Ratios for Risk Factors Associated with Nerve Injury 90 Days After Total Knee Arthroplasty. by Rahul H. Jayaram (21463899)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 305
    Univariate and Multivariate analysis of risk factors for nerve injury 90-days after TKA.

    Univariate and Multivariate analysis of risk factors for nerve injury 90-days after TKA. by Rahul H. Jayaram (21463899)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 306
    Summary of post-treatment disease course measures from MDMA-AT publications.

    Summary of post-treatment disease course measures from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 307
    Study selection criteria.

    Study selection criteria. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 308
    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.

    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 309
    Disease course measures after the PTSD treatments.

    Disease course measures after the PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 310
    PICOS criteria for the SLR.

    PICOS criteria for the SLR. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 311
    Summary of post-treatment CAPS score changes from MDMA-AT publications.

    Summary of post-treatment CAPS score changes from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 312
    Summary of post-treatment disease course measures from off-label medications clinical trials.

    Summary of post-treatment disease course measures from off-label medications clinical trials. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 313
    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.

    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 314
    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.

    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 315
    Summary of post-treatment disease course measures from clinical trials with psychotherapies.

    Summary of post-treatment disease course measures from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 316
    PRISMA flow chart.

    PRISMA flow chart. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 317
    Summary of clinical efficacy of relevant PTSD treatments.

    Summary of clinical efficacy of relevant PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 318
    Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.

    Post-treatment CAPS score changes from clinical trials with off-label PTSD medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 319
    Statins induced flatter neuronal somas.

    Statins induced flatter neuronal somas. by Shuk C. Tsoi (21192243)

    Published 2025
    Save to List
    Saved in:
  20. 320
    Spearman’s correlation coefficients between mean scores of each S-Hab-Q factor and the AQ subscales.

    Spearman’s correlation coefficients between mean scores of each S-Hab-Q factor and the AQ subscales. by Vincenza Tarantino (182506)

    Published 2024
    Save to List
    Saved in:

Search Tools: